John Peter Gutfreund

Insider Reports History

Entity
Individual
Location
767 5 Th Avenue, 44 Th Floor, New York, NY
Signature
/s/ John Peter Gutfreund
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Peter Gutfreund:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Oncocyte Corp Former Director Common Stock, no par value 715K $154K $0.21 Jun 30, 2023 Direct
Oncocyte Corp Former Director Option to Purchase Common Stock 45K Aug 15, 2022 Direct
Oncocyte Corp Former Director Warrants to Purchase Common Stock 45K Jun 30, 2023 Direct
Oncocyte Corp Former Director Common Stock, no par value 0 $0.21 Jun 30, 2023 Indirect
Oncocyte Corp Former Director Series A Convertible Preferred Stock 0 Apr 3, 2023 Direct
Oncocyte Corp Former Director Warrants to Purchase Common Stock 0 Jun 30, 2023 Indirect

Insider Reports Filed by John Peter Gutfreund

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OCX Oncocyte Corp Jun 30, 2023 2 $0 4 Jul 3, 2023 Former Director
OCX Oncocyte Corp Apr 3, 2023 3 $604K 4 Apr 5, 2023 Director
OCX Oncocyte Corp Dec 23, 2022 1 $24.7K 4 Dec 28, 2022 Director
OCX Oncocyte Corp Aug 15, 2022 3 $23.3K 4 Aug 17, 2022 Director
OCX Oncocyte Corp Jul 28, 2022 0 $0 3 Aug 8, 2022 Director